Oseltamivir becomes plentiful--but still not cheap.
Enserink
Martin
M
D000081:Acetamides / Q000008:administration & dosage / Q000138:chemical synthesis / Q000191:economics / Q000600:supply & distribution; D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage / Q000138:chemical synthesis / Q000191:economics / Q000600:supply & distribution; D002626:Chemistry, Pharmaceutical; D003906:Developing Countries; D016527:Drug Costs; D004345:Drug Industry; D016568:Drugs, Generic / Q000138:chemical synthesis / Q000191:economics / Q000600:supply & distribution; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype / Q000187:drug effects; D007251:Influenza, Human / Q000188:drug therapy* / Q000517:prevention & control; D009976:Orthomyxoviridae Infections / Q000188:drug therapy; D053139:Oseltamivir; D010330:Patents as Topic; D016032:Randomized Controlled Trials as Topic
D000081:Acetamides; D000998:Antiviral Agents; D016568:Drugs, Generic; D053139:Oseltamivir